Dr. Michael Sperling gives us an inside look at the Jefferson University approach to epilepsy care, the institution’s firsthand use of novel interventions and methods, and their process for broaching the topic of epilepsy surgery with patients who are ideal candidates.
Heather Saunders, MPH, RN, CIC, is an infection preventionist and a member of ICT’s Editorial Advisory Board. She’s the Director of Infection Control for the Office of Population Health at Johns Hopkins University and she joins Deep Dive to talk about the many issues surrounding infection prevention at nursing homes.
CareQuest Institute for Oral Health, in collaboration with Dental Data Exchange Project recently developed and published the first implementation guide to help bridge the communication gap between primary care and oral health care. This publication—the HL7® CDA® R2 Implementation Guide: Dental Data Exchange, Release 1, STU 1 - US Realm—is designed to facilitate care coordination and create best practices for electronic exchange of patient data between dental and medical professionals. We spoke with Sean Boynes, DMD, CareQuest Institute for Oral Health’s vice president of health improvement about what’s in the implementation guide and the impact they hope it will have on patient care, and cooperation between medical and dental care providers
Experts attending and presenting at The Metabolic Institute of America (TMIOA) 5th Annual Heart in Diabetes meeting in New York, NY, this month. The question asked to our experts was: "What is still needed to improve the collaboration between heart disease and diabetes specialists?"
Ike Devji and Anthony Williams join Second Opinion to discuss the impact of Covid-19 on high-earner assets and finances, alternatives to hedge against downside risk, tax changes, and more.
A panel of experts answers the question: What is behind the sharp, season atypical cases of respiratory disease, particularly RSV?
Dr. Brett Nowlan discusses how he navigates through the ebbs and flows of virtual conference season as both a presenter and attendee.
Shereen Stutz and Mark Alwardt of McKesson discuss how the rise in oral oncolytics during the COVID-19 pandemic allowed pharmacies to be more innovative and to become an even more integrated part of the oncology care team.
Although disparities in health care were already well known and researched, the COVID-19 pandemic really highlighted the impact disparities have. At The American Journal of Managed Care’s Patient-Centered Oncology Care conference, speakers explained some actionable steps that can be taken to address disparities in the short term.
An immediate care facility aimed at bridging the gap between cancer centers and emergency rooms is coming to Winship Cancer Institute of Emory University. Charise Gleason, MSN, NP-BC, AOCNP, the advance practice provider chief at Winship Cancer Institute of Emory University, discusses why having a dedicated cancer urgent care center would improve patient care by making cancer treatment plans seamless while also helping patients avoid exposure to infectious diseases in emergency waiting rooms.
Four Oncology Nurse Champions answer what excellence in oncology care means to them and offer advice for other nurses in the field.
James L. Knoll, IV, MD, gives an overview of his long career in forensic psychiatry, where he has worked with difficult and potentially dangerous patients. In this interview he discusses the relationship between psychiatric illnesses and criminal behavior, the challenges of treating patients in a correctional setting, and how to leave a stressful workplace behind at the end of the day.
Dr. Matthew Weissenbach, and Dr. Steve Mok both from Wolters Kluwer Health discuss a recent Pew Charitable Trusts study looking at antibiotic use in hospitalized COVID-19 patients. They provide an overview of the data associated with the study, discuss the findings, and offer some insights looking at antibiotic usage in this patient population.
The epidemic of chronic obesity in the US is driving increases in a wide range of other dangerous and deadly chronic illnesses. Prevention and management of overweight and obesity are rightly the concern of primary care but there are myriad challenges for both patients and physicians to arresting or reversing the process of unhealthy weight gain. There now are several physiologic that act on the physiologic underpinnings of obesity and may significantly enhance the success of patients’ efforts at behavioral change (eg, diet and physical activity).
Doctor Kevin Kavanagh has been out in front of developments during the COVID pandemic, sometimes way out in front. He called for booster shots for older Americans weeks before the CDC did. He also foresaw, and wrote about, the dangers the delta variant presents before most other medical experts did. But what made this retired ear, nose and throat surgeon take such a deep dive into the world of infection prevention?
The editors at CancerNetwork® met with some thought leaders in the field of oncology to discuss their research and how these findings have the potential to impact the standard of care going forward. During some of these discussions, we checked in to see how the lasting effects of the COVID-19 pandemic have led to adjustments at oncology clinics and what new standard are likely here to stay as a result.
In this segment, Dr. Muthiah Vaduganathan breaks down a recent study he led, which was published in JAMA Cardiology, examining the potential patient population and impact of optimal prescribing based on a label expansion from the FDA for Sacubitril/\Valsartan in February 2021.
Dr. Angela Fusaro discusses Physician 360, a telemedicine program that connects patients to health care providers. Dr. Fusaro discusses how Physician 360 works and the mission and design behind the telemedicine program. She discusses how COVID shine light on the way small independent pharmacies are underutilized and overlooked. Additionally, she talks about how this varies/compares to going to the doctor for a test and the quality of patients’ lives in designing these kits and why translating clinical insight into marketable products so effective in today’s world.
The conversation focused on an article published in the journal ONCOLOGY titled, “Routine Breast Cancer Screening in Average-Risk Women Younger Than 50 Years: Current Paradigms Based on National Guidelines.” The two experts discussed the current paradigms for breast cancer screenings, risks and benefits of screening women between the ages of 40 and 49 years, different imaging techniques and the role each technique plays, as well as the future direction of breast cancer screening.
Three experts in the care of neurologic disease offer a look into the motivations behind some of their most recent explorations into the trends in this patient population, ranging from evaluations of disparities in care, smoking cessation rates among patients, and the risk factors for ischemic stroke.
Next month, the American Academy of Pediatrics will be publishing Dr. Candice Jones' book, “High Five Discipline: Positive parenting for happy, healthy, well-behaved kids.” We took a deep dive into lessons that both pediatricians and parents can glean from this book, from the difference between positive and negative parenting, to how to handle those sometimes-tumultuous teenage years.
Dr. Jennifer Weiss explains the research and goals behind a four-year endeavor at the University of Wisconsin-Madison Carbone Cancer Center exploring ways to improve screening rates for colorectal cancer in rural clinics. She also provides background on the disease, which has seen a rapid increase in early onset cases for unknown reasons.
Experts in the field of myeloproliferative neoplasms discusses the symptoms associated with myelofibrosis, as well as best practices for managing them.
Christie Ballantyne, MD, Director of the Center for Cardiometabolic Disease Prevention at Baylor College of Medicine, discussed the possible issues his field sees in the rate of innovation and research relative to the process of regulation. Ballantyne also highlighted upcoming drug classes he has the most interest in for cardiovascular disease management, as well as his reasoning for why currently available agents are not being best utilized still.
Jurriaan Peters, MD, and Eric Segal, MD join Second Opinion for the second time - this time to talk about the multiple paths to happiness while working in medicine.
On this episode of Behind the Science, we ask 4 clinicians this question: What innovation or area of research is going to have the biggest impact on dentistry in the next 10 years?
Stephanie Mercado, CEO and Executive Director of NAHQ (National Association for Healthcare Quality) discusses NAHQ’s mission to improve healthcare quality and what improvements, as well as shortcomings have been made. Mercado also shared what steps need to be taken in healthcare as a whole to continue improving the quality of care.
Josh Ludwig spoke with CancerNetwork about how ScaleReady, a joint venture between industry leaders launched in January, is equipped to make cell and gene therapy practical and viable. Ludwig touched on the partnership, as well the G-Rex platform, important processes for successful commercialization of cell and gene therapy, and what’s next for ScaleReady.
Experts discuss recent abortion legislation, such as in New Hampshire and Texas SB8.
Urologist Matthew J. Allaway, MD, gives an overview of transrectal vs transperineal biopsies, discusses how his own cancer battle influenced his professional path, and how his PrecisionPoint system aids in the detection of prostate cancer.
